hydrocortisone acetate 25 MG Rectal Suppository [Anucort-HC]
- RxCUI
- 1291101
- RxNorm name
- hydrocortisone acetate 25 MG Rectal Suppository [Anucort-HC]
- Display name
- ANUCORT-HC (Rectal)
- Full name
- hydrocortisone acetate 25 MG Rectal Suppository [Anucort-HC]
- Term type
- SBD
- Status
- Active
- Strength
- 25 mg
- Dose form
- Suppository
- Route
- Rectal
- Updated
- 2026-07-20 06:52:39
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 062012
- Active start
- 062012
- Multiple ingredient
- NO
- Branded
- YES
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| hydrocortisone acetate | 25 MG / 1 EACH | hydrocortisone | hydrocortisone acetate |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Rectal Suppository | 316978 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| hydrocortisone | 5492 |
Source Vocabulary Codes#
| Code type | Value | Category |
|---|---|---|
| PRESCRIBABLE | Y | ATTRIBUTES |
| RXNAV_STR | Anucort-HC 25 MG Rectal Suppository | NAMES |
| RxNorm Name | hydrocortisone acetate 25 MG Rectal Suppository [Anucort-HC] | NAMES |
| RxNorm Synonym | Anucort-HC 25 MG Rectal Suppository | NAMES |
| TTY | SBD | ATTRIBUTES |
| SPL_SET_ID | f0f5a107-1236-8e1a-815d-dec8007c2bc9 | CODES |
| RxCUI | 1291101 | CODES |
| MMSL_CODE | BD271 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0713-0503-01 | 0713-0503 | ANUCORT-HC Hydrocortisone Acetate | Cosette Pharmaceuticals, Inc. | |
| 0713-0503-12 | 0713-0503 | ANUCORT-HC Hydrocortisone Acetate | Cosette Pharmaceuticals, Inc. | |
| 0713-0503-24 | 0713-0503 | ANUCORT-HC Hydrocortisone Acetate | Cosette Pharmaceuticals, Inc. |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ANUCORT-HC | HYDROCORTISONE ACETATE | Cosette Pharmaceuticals, Inc. | f0f5a107-1236-8e1a-815d-dec8007c2bc9 | 2023-11-22 | Adverse reactions | 0713-0503-12 0713-0503-24 0713-0503-01 0713-0503 00713050324 00713050312 00713050301 1291101 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| f0f5a107-1236-8e1a-815d-dec8007c2bc9 | hydrocortisone acetate 25 MG Rectal Suppository [Anucort-HC] | SBD | 9 | ANUCORT-HC TM | 20231122 |
| f0f5a107-1236-8e1a-815d-dec8007c2bc9 | Anucort-HC 25 MG Rectal Suppository | SY | 9 | ANUCORT-HC TM | 20231122 |
| f0f5a107-1236-8e1a-815d-dec8007c2bc9 | ANUCORT-HC 25 MG Rectal Suppository | PSN | 9 | ANUCORT-HC TM | 20231122 |
DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| f0f5a107-1236-8e1a-815d-dec8007c2bc9 | ANUCORT-HC TM | Cosette Pharmaceuticals, Inc. | Cosette Pharmaceuticals NC Laboratories, LLC | 20231122 |
| a9cd4b15-eb0c-4feb-88cf-747bd7dbc963 | ANUCORT-HC TM | A-S Medication Solutions | 20180226 |
| 0f78caf1-8836-4e9c-bc43-a9c395f8fc33 | National Council for Prescription Drug Programs | 20120724 | |
| 83a00577-782e-4ce5-89d1-1c7a470f9bf7 | National Council for Prescription Drug Programs | 20120724 | |
| b48dbde1-3c14-466b-b96c-7ac12332c048 | National Council for Prescription Drug Programs | 20120724 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | S02BA | Corticosteroids | ATC1-4 | hydrocortisone | |
| ATC | C05AA | Corticosteroids | ATC1-4 | hydrocortisone | |
| ATC | A07EA | Corticosteroids acting locally | ATC1-4 | hydrocortisone | |
| ATC | A01AC | Corticosteroids for local oral treatment | ATC1-4 | hydrocortisone | |
| ATC | S01BA | Corticosteroids, plain | ATC1-4 | hydrocortisone | |
| ATC | D07AA | Corticosteroids, weak (group I) | ATC1-4 | hydrocortisone | |
| ATC | D07XA | Corticosteroids, weak, other combinations | ATC1-4 | hydrocortisone | |
| ATC | S01CB | Corticosteroids/antiinfectives/mydriatics in combination | ATC1-4 | hydrocortisone | |
| ATC | H02AB | Glucocorticoids | ATC1-4 | hydrocortisone | |
| FDASPL | N0000175576 | Corticosteroid | EPC | has_epc | hydrocortisone |
| MEDRT | D006854 | Hydrocortisone | CHEM | has_ingredient | hydrocortisone |
| MEDRT | D006854 | Hydrocortisone | CHEM | has_ingredient | hydrocortisone acetate |
| MEDRT | D000312 | Adrenal Hyperplasia, Congenital | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D000312 | Adrenal Hyperplasia, Congenital | DISEASE | may_treat | hydrocortisone |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D000309 | Adrenal Insufficiency | DISEASE | may_treat | hydrocortisone |
| MEDRT | D003093 | Colitis, Ulcerative | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D003093 | Colitis, Ulcerative | DISEASE | may_treat | hydrocortisone |
| MEDRT | D003877 | Dermatitis, Contact | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D003877 | Dermatitis, Contact | DISEASE | may_treat | hydrocortisone |
| MEDRT | D003881 | Dermatomycoses | DISEASE | ci_with | hydrocortisone acetate |
| MEDRT | D003881 | Dermatomycoses | DISEASE | ci_with | hydrocortisone |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | hydrocortisone acetate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | hydrocortisone |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D005148 | Facial Dermatoses | DISEASE | may_treat | hydrocortisone |
| MEDRT | D005533 | Foot Dermatoses | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D005533 | Foot Dermatoses | DISEASE | may_treat | hydrocortisone |
| MEDRT | D006229 | Hand Dermatoses | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D006229 | Hand Dermatoses | DISEASE | may_treat | hydrocortisone |
| MEDRT | D006484 | Hemorrhoids | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D006484 | Hemorrhoids | DISEASE | may_treat | hydrocortisone |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D007249 | Inflammation | DISEASE | may_treat | hydrocortisone |
| MEDRT | D007868 | Leg Dermatoses | DISEASE | may_treat | hydrocortisone |
| MEDRT | D007868 | Leg Dermatoses | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D011538 | Pruritus Ani | DISEASE | may_treat | hydrocortisone |
| MEDRT | D012216 | Rheumatic Diseases | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D012216 | Rheumatic Diseases | DISEASE | may_treat | hydrocortisone |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D012536 | Scalp Dermatoses | DISEASE | may_treat | hydrocortisone |
| MEDRT | D012769 | Shock | DISEASE | may_treat | hydrocortisone |
| MEDRT | D012769 | Shock | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D012876 | Skin Diseases, Parasitic | DISEASE | ci_with | hydrocortisone |
| MEDRT | D012876 | Skin Diseases, Parasitic | DISEASE | ci_with | hydrocortisone acetate |
| MEDRT | D017193 | Skin Diseases, Viral | DISEASE | ci_with | hydrocortisone |
| MEDRT | D017193 | Skin Diseases, Viral | DISEASE | ci_with | hydrocortisone acetate |
| MEDRT | D013224 | Status Asthmaticus | DISEASE | may_treat | hydrocortisone acetate |
| MEDRT | D013224 | Status Asthmaticus | DISEASE | may_treat | hydrocortisone |
| MEDRT | D014382 | Tuberculosis, Cutaneous | DISEASE | ci_with | hydrocortisone |
| MEDRT | D014382 | Tuberculosis, Cutaneous | DISEASE | ci_with | hydrocortisone acetate |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | hydrocortisone acetate |
| MEDRT | N0000000159 | Glucocorticoid Receptor Agonists | MOA | has_moa | hydrocortisone |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | hydrocortisone |
| MEDRT | N0000000134 | Lipoxygenase Inhibitors | MOA | has_moa | hydrocortisone acetate |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000008327 | Carbohydrate Metabolism Alteration | PE | has_pe | hydrocortisone |
| MEDRT | N0000010253 | Decreased Capillary Permeability | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000010253 | Decreased Capillary Permeability | PE | has_pe | hydrocortisone |
| MEDRT | N0000010248 | Decreased Fibroblast Migration | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000010248 | Decreased Fibroblast Migration | PE | has_pe | hydrocortisone |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000008645 | Decreased Glucocorticoid Secretion | PE | has_pe | hydrocortisone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | hydrocortisone |
| MEDRT | N0000008681 | Decreased Leukotriene Activity | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000008700 | Decreased Lysosomal Function | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000008700 | Decreased Lysosomal Function | PE | has_pe | hydrocortisone |
| MEDRT | N0000010246 | Decreased Polymorphonuclear Leukocyte Migration | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000010246 | Decreased Polymorphonuclear Leukocyte Migration | PE | has_pe | hydrocortisone |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000008834 | Decreased Prostaglandin Activity | PE | has_pe | hydrocortisone |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | hydrocortisone |
| MEDRT | N0000008841 | Decreased Protein Synthesis | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | hydrocortisone |
| MEDRT | N0000009004 | Decreased Thromboxane Activity | PE | has_pe | hydrocortisone acetate |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | hydrocortisone |
| MEDRT | N0000009739 | Lipid Metabolism Alteration | PE | has_pe | hydrocortisone acetate |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 25 MG (expressed as hydrocortisone acetate) |
| ATTRIBUTES | GENERAL_CARDINALITY | SINGLE |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | PRESCRIBABLE | Y |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 0 |
| ATTRIBUTES | TTY | SBD |
| CODES | MMSL_CODE | BD271 |
| CODES | RxCUI | 1291101 |
| CODES | SPL_SET_ID | f0f5a107-1236-8e1a-815d-dec8007c2bc9 |
| NAMES | Prescribable Synonym | ANUCORT-HC 25 MG Rectal Suppository |
| NAMES | RXNAV_STR | Anucort-HC 25 MG Rectal Suppository |
| NAMES | RxNorm Name | hydrocortisone acetate 25 MG Rectal Suppository [Anucort-HC] |
| NAMES | RxNorm Synonym | Anucort-HC 25 MG Rectal Suppository |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |